Effects of BNT162b2 Covid-19 Vaccine Booster in Long-Term Care Facilities in Israel
Effects of BNT162b2 Covid-19 Vaccine Booster in Long-Term Care Facilities in Israel
About this item
Full title
Author / Creator
Publisher
United States: Massachusetts Medical Society
Journal title
Language
English
Formats
Publication information
Publisher
United States: Massachusetts Medical Society
Subjects
More information
Scope and Contents
Contents
During a surge in cases of Covid-19 in Israel, a rapid deployment of BNT162b2 booster injections was initiated in long-term care facilities over a 3-week period in July. When infection rates were increasing in the general population, rates in long-term care facilities decreased by 71%, and hospitalization rates fell by 80%.
Alternative Titles
Full title
Effects of BNT162b2 Covid-19 Vaccine Booster in Long-Term Care Facilities in Israel
Authors, Artists and Contributors
Identifiers
Primary Identifiers
Record Identifier
TN_cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_8757568
Permalink
https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_8757568
Other Identifiers
ISSN
0028-4793,1533-4406
E-ISSN
1533-4406
DOI
10.1056/NEJMc2117385
